NYSE: VRX

Featured Story

VRX Stock Price Falls Again Today Following New Default Warning

By Diane Alter, Contributing Writer, Money Morning - April 13, 2016

The VRX stock price is falling again today following new default warnings for Valeant Pharmaceuticals.

Valeant shares are now down 70% year to date, and we still think they have even more room to fall.

Here's what you need to know about the VRX stock price today, and what's next for the company.

Article Index

VRX Stock Price Falls Again Today Following New Default Warning

By Diane Alter, Contributing Writer, Money Morning - April 13, 2016

The VRX stock price is falling again today following new default warnings for Valeant Pharmaceuticals.

Valeant shares are now down 70% year to date, and we still think they have even more room to fall.

Here's what you need to know about the VRX stock price today, and what's next for the company.

The Valeant Stock Price Just Tanked Again and We Called It

By Diane Alter, Contributing Writer, Money Morning - April 12, 2016

The Valeant stock price tanked 7% Monday and fell further today as things keep getting worse for the embattled drug company.

We called the Valeant stock price plunge last summer and remain bearish on the VRX stock price in 2016.

Here's what caused the latest rout, which backs our cautious stance...

Why the VRX Stock Price Soared 15% Today – and What to Expect Now

By Diane Alter, Contributing Writer, Money Morning - April 5, 2016

The VRX stock price soared 15% to $29.91 today after the embattled drug company said no additional restatements are necessary after an internal audit.

The company now is facing anxious creditors of its $11 billion secured loans.

Valeant's woes are far from over...

VRX Stock Tanks Again Today After Hiking Drug Price 100%

By Jack Delaney, Associate Editor, Money Morning - March 28, 2016

The VRX stock price has plummeted 82% in the last six months because of predatory business practices.

Money Morning has covered the fall of Valeant Pharmaceuticals since October 2015, and our readers have made a profit of 700%.

And after Valeant just came under fire for increasing the price of a female libido pill from $400 to $800, it appears Valeant isn't ready to give up its predatory business model. That's more bad news for VRX shareholders...

Valeant Stock Price Soars Today – Should Investors Buy Now?

By Diane Alter, Contributing Writer, Money Morning - March 21, 2016

It has been an incredibly volatile day for the Valeant stock price. VRX stock jumped more than 15% to $31.59 this morning (Monday) after the pharmaceutical giant announced sweeping changes to its board.

Valeant Pharmaceutics Internationa Inc. (NYSE: VRX) shares were briefly halted after the news broke. When trading resumed, Valeant stock plunged. Ten minutes into today's session, the Valeant stock price was down 1% to a new 52-week low of $26.

Here's what is next for Valeant stock in 2016...

The Valeant Stock Price Crashed – and We Made a 700% Profit

By Diane Alter, Contributing Writer, Money Morning - March 18, 2016

The Valeant stock price has crashed 88% over the last six months, and the stock shows no sign of recovering.

And while many investors were crushed by the loss -- including famed activist Bill Ackman, who reportedly lost $1 billion on the stock - our readers made a profit of 700%.

Before we get to that massive profit, here's why Valeant Pharmaceuticals International Inc. (NYSE: VRX) stock crashed 58% this week, and why it's still falling...

What's Next for the Valeant Stock Price After Today's 40% Crash

By Diane Alter, Contributing Writer, Money Morning - March 15, 2016

The Valeant stock price crashed nearly 39% today (Tuesday) to $40.00 after the company reported dismal earnings and weak guidance for 2016.

But there's an even bigger issue aside from earnings that will move the Valeant stock price in 2016. Before we get into where the Valeant Pharmaceutical International Inc. (NYSE: VRX) stock price is headed from here, here's why the pharmaceutical stock is crashing today...

Should I Buy Valeant Stock After Q4 2015 Earnings?

By Jack Delaney, Associate Editor, Money Morning - March 15, 2016

Valeant not only missed expectations in its Q4 2015 earnings report, but also provided a bleak outlook for 2016.

The drug maker has dealt with countless scandals over the past six months, which has made the Valeant stock price plunge over 78% from its 52-week high of $263.81.

Now, some on Wall Street are saying that this is a great time to buy VRX at a discount. But here's what you really need to know...

Why the Valeant Stock Price Is Crashing and What's Next for the Stock in 2016

By Diane Alter, Contributing Writer, Money Morning - March 1, 2016

The Valeant stock price is in free fall. Valeant stock tumbled another 8% to $59.88 today (Tuesday) after crashing 18% Monday following reports that the beleaguered company is under investigation by the U.S. Securities and Exchange Commission (SEC).

And according to Money Morning experts, the Valeant stock price has even further to fall in 2016. First, here's why the stock has crashed this week...

Where the VRX Stock Price Is Headed in 2016

By Alex McGuire, Associate Editor, Money Morning • @AlexMcGuire92 - December 29, 2015

The VRX stock price saw one of its worst single-day performances of the year yesterday.

Shares plunged after CEO J. Michael Pearson took a medical leave of absence due to pneumonia.

Now investors are wondering if the stock is bottoming out and ready to move higher in 2016...

The Five Most Hated Companies of 2015

By Money Morning Staff Reports, Money Morning - December 23, 2015

Our "most hated companies 2015" list includes five companies that stole, poisoned, and defrauded their way to profits this year - and did so unapologetically.

Have a look at what these loathsome companies accomplished in 12 short months...

Why the VRX Stock Price Is Falling Again This Week and Where It's Headed

By Diane Alter, Contributing Writer, Money Morning - December 21, 2015

The Valeant Pharmaceutical International Inc. (NYSE: VRX) stock price has come under pressure yet again this week following a new downgrade and significantly lowered company guidance.

Late last week, Valeant lowered its Q4 outlook and guided Q1 fiscal 2016 sales and earnings below Wall Street estimates.

Here's why we see the VRX stock price drop continuing into 2016...

4 of the Most Outrageous Drug Price Increases in 2015

By Money Morning Staff Reports, Money Morning - December 9, 2015

Four of the most outrageous drug price increases in 2015 were born purely of greed...

Most of us have heard about Turing Pharmaceutical's CEO Martin Shkreli's infamous price-gouging incident.

But check out our chart to see four drug price hikes that were even more massive this year...

Don't Buy In to the Valeant Stock Hype

By Michael A. Robinson, Defense + Tech Specialist, Money Morning • @Robinson_STI - December 3, 2015

There's been a ton of online chatter claiming that Valeant stock has become a screaming bargain.

And sure, it sounds like a bottom-feeder's dream come true. Since its Aug. 5 high, Valeant stock has dropped more than 65%. If it regained just 69% of its previous high, it would double.

But don't believe the hype. This is a deeply troubled company you should stay well away from.

Let me show you why you'll be glad you avoided this company at all costs...

Why Valeant (NYSE: VRX) Stock Price Collapse Will Continue from Here

By Diane Alter, Contributing Writer, Money Morning - November 6, 2015

The Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock price has dropped 44% year to date and nearly 80% over the last three months.

While some are saying VRX stock has now become undervalued, Money Morning Global Credit Strategist Michael Lewitt says the Valeant stock price will only continue to fall.

Here's why...